Latest Analysis

1049 tickers · updated regularly
Ranks this page's recent reports by score.
SLB N.V.
SLB·Energy
B ★★★Hold
Current$52.42
Target$61.34
Return+17.0%
Jul 27, 2026

SLB combines explosive structural upside via AI data center power provision and high-margin digital software with the near-term cyclical drag of Middle Eastern rig demobilizations and post-merger equity dilution.

Score
75
Verizon Communications Inc.
VZ·Communication Services
A ★★★★Buy
Current$46.38
Target$53.00
Return+14.3%
Jul 27, 2026

Verizon offers an elite, highly secure 6.10% dividend and deep value multiples driven by record FCF and margins, though its massive $136 billion debt load heavily restricts aggressive multiple expansion.

Score
87
HCA Healthcare, Inc.
HCA·Healthcare
B ★★★Hold
Current$382.19
Target$425.00
Return+11.2%
Jul 27, 2026

An unmatched, highly profitable acute-care monopoly violently aggressively shrinking its share count, currently paralyzed by a billion-dollar regulatory headwind as millions of patients are purged from insurance exchanges.

Score
82
American Express Company
AXP·Financials
A ★★★★Buy
Current$326.17
Target$375.00
Return+15.0%
Jul 27, 2026

An unmatched closed-loop premium payment network extracting highly lucrative merchant fees from resilient, affluent demographics, though long-term margins face persistent pressure from escalating mega-bank rewards warfare.

Score
92
Cincinnati Financial Corporation
CINF·Financials
B ★★★Hold
Current$182.81
Target$196.00
Return+7.2%
Jul 27, 2026

Cincinnati Financial is a uniquely structured, agency-driven P&C compounder with a fortress balance sheet and a 65-year dividend streak, but its current valuation premium limits near-term upside.

Score
81
Aramark
ARMK·Industrials
B ★★★Hold
Current$57.18
Target$68.00
Return+18.9%
Jul 26, 2026

Aramark pairs the impenetrable, highly recession-resistant cash flows of an oligopolistic food service giant with the explosive, structural upside of a premier AI data center workforce infrastructure play, though investors must remain forever vigilant against potential margin compression from sudden, severe agricultural inflation spikes.

Score
84
Hormel Foods Corporation
HRL·Consumer Staples
B ★★★Hold
Current$25.31
Target$28.00
Return+10.6%
Jul 27, 2026

Hormel Foods pairs a pristine 59-year dividend aristocrat legacy and strong brand moat with near-term margin recovery potential, though a premium valuation compared to peers warrants a Hold recommendation while interim leadership executes the portfolio transformation.

Score
76
The Cooper Companies, Inc.
COO·Healthcare
A ★★★★Buy
Current$70.31
Target$85.65
Return+21.8%
Jul 26, 2026

The stock represents an immensely undervalued vision oligopolist that will violently rerate higher once the $4.1 billion CooperSurgical divestiture isolates its massive free cash flow engine from legacy litigation noise.

Score
86
Ally Financial Inc.
ALLY·Financials
A ★★★★Buy
Current$44.61
Target$55.13
Return+23.6%
Jul 27, 2026

Ally provides exceptional capital return and massive NIM expansion driven by its dominant digital bank and dealer network, though its structural reliance on the cyclical used car market and interest rate volatility requires vigilant monitoring.

Score
89
Tencent Music Entertainment Group
TME·Communication Services
A ★★★★Buy
Current$8.86
Target$15.40
Return+73.8%
Jul 27, 2026

Tencent Music offers an elite, high-margin digital monopoly trading at single-digit multiples, though investors must stomach the perpetual geopolitical and regulatory overhang inherent to Chinese equities.

Score
88
Globe Life Inc.
GL·Financials
B ★★★Hold
Current$173.48
Target$195.00
Return+12.4%
Jul 27, 2026

Globe Life offers a highly profitable, cash-generative insurance model with an incredibly durable ROE, but near-term health margin compression and heavy insider selling warrant a neutral stance.

Score
80
Medpace Holdings, Inc.
MEDP·Healthcare
B ★★★Hold
Current$605.82
Target$624.00
Return+3.0%
Jul 27, 2026

Medpace commands exceptional margins and industry-leading ROIC through its disciplined FSO model targeting small biopharma, but high valuation multiples and biotech funding cyclicality warrant a neutral entry stance.

Score
83
Tractor Supply Company
TSCO·Consumer Discretionary
C ★★Sell
Current$31.02
Jul 27, 2026

Tractor Supply possesses an impregnable real-estate moat and trades at cycle-low valuations, but negative store traffic, shattered management guidance, and a contracting rural consumer base make it a perilous falling knife.

Score
72
Ovintiv Inc.
OVV·Energy
A ★★★★Buy
Current$63.13
Target$71.86
Return+13.8%
Jul 27, 2026

Ovintiv offers elite free cash flow generation and aggressive shareholder returns via massive buybacks, but remains inherently vulnerable to cyclical downturns in global commodity pricing.

Score
91
Joint Stock Company Kaspi.kz
KSPI·Financials
A ★★★★Buy
Current$85.79
Target$118.00
Return+37.5%
Jul 27, 2026

Kaspi.kz is an elite, cash-printing Kazakhstani Super App trading at a deeply distressed multiple, though investors must aggressively weather near-term margin compression and geopolitical anxiety as it scales into the hyper-competitive Turkish market.

Score
87
SolarEdge Technologies, Inc.
SEDG·Technology
B ★★★Hold
Current$42.60
Target$65.00
Return+52.6%
Jul 26, 2026

SolarEdge is executing a painful but necessary turnaround, exiting unprofitable divisions to focus on core solar and AI data centers, offering significant upside if execution holds.

Score
79
The RealReal, Inc.
REAL·Consumer Discretionary
A ★★★★Buy
Current$11.37
Target$17.25
Return+51.7%
Jul 26, 2026

The RealReal offers an unmatched monopoly on authenticated luxury resale driven by explosive AI margin expansion, overcoming the core bear concern of macroeconomic sensitivity through newly achieved, self-sustaining free cash flow.

Score
88
StubHub Holdings, Inc.
STUB·Communication Services
B ★★★Hold
Current$8.27
Target$13.00
Return+57.2%
Jul 26, 2026

StubHub is an aggressively undervalued, cash-printing digital monopoly trading at distressed multiples, but remains uninvestable for conservative capital until the CEO's severe conflicts of interest and the existential threat of federal resale price-capping legislation are resolved.

Score
75
NIQ Global Intelligence plc
NIQ·Technology
A ★★★★Buy
Current$11.07
Target$20.00
Return+80.7%
Jul 26, 2026

NIQ is a monopolistic data giant trading at a highly distressed 0.7x revenue multiple due to LBO debt fears, offering immense upside as AI SaaS products expand margins, though it remains vulnerable to prolonged high interest rates and retail data internalization.

Score
87
Huntington Bancshares Incorporated
HBAN·Financials
B ★★★Hold
Current$17.36
Target$21.85
Return+25.9%
Jul 26, 2026

Huntington offers an elite 17.5% ROTCE and massive upside from Cadence synergies, but near-term upside is capped by creeping nonperforming assets and the heavy burden of absorbing 40% historical share dilution.

Score
84
Tenet Healthcare Corporation
THC·Healthcare
A ★★★★Buy
Current$233.20
Target$285.00
Return+22.2%
Jul 26, 2026

Tenet is a cash-gushing compounder structurally expanding margins via its market-leading USPI ambulatory platform, though escalating uninsured patient volumes in its legacy hospital segment threaten to drag on overall profitability.

Score
87
SS&C Technologies Holdings, Inc.
SSNC·Technology
S ★★★★★Strong Buy
Current$73.88
Target$107.06
Return+44.9%
Jul 26, 2026

SS&C pairs an impenetrable, high-margin financial software moat with deeply undervalued Forward P/E multiples and massive share buybacks, creating an explosive EPS compounding engine.

Score
96
Honeywell International Inc.
HON·Industrials
A ★★★★Buy
Current$246.27
Target$275.00
Return+11.7%
Jul 26, 2026

An elite automation leader wielding ultimate switching costs to monopolize the data center and energy transition boom, whose only flaw is the short-term valuation burden of a 30x forward P/E.

Score
85
Plains All American Pipeline, L.P.
PAA·Energy
B ★★★Hold
Current$24.60
Target$25.50
Return+3.7%
Jul 26, 2026

Plains All American offers a highly secure 6.8% yield backed by an irreplaceable Permian infrastructure moat and massive free cash flow, though its mature growth profile and fair valuation limit prospects for aggressive capital appreciation.

Score
75